Cargando…

siRNA targeting decoy receptor 3 enhances the sensitivity of gastric carcinoma cells to 5-fluorouracil

In order to investigate the effects of RNA interference of decoy receptor 3 (DcR3) on the sensitivity of gastric cancer cells to 5-fluorouracil (5-FU) and the relevant mechanisms, siRNA against DcR3 was transfected into the gastric cancer cell line AGS. AGS cells were treated with different doses of...

Descripción completa

Detalles Bibliográficos
Autores principales:	XU, XIAO-TAO, TAO, ZE-ZHANG, SONG, QI-BIN, YAO, YI, RUAN, PENG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503848/ https://www.ncbi.nlm.nih.gov/pubmed/23181119 http://dx.doi.org/10.3892/etm.2012.606

Ejemplares similares

A dual function TAR Decoy serves as an anti-HIV siRNA delivery vehicle
por: Unwalla, Hoshang J, et al.
Publicado: (2010)

Effect of combination therapy of siRNA targeting growth hormone receptor and 5-fluorouracil in hepatic metastasis of colon cancer
por: ZHOU, DONG, et al.
Publicado: (2015)

siRNA-mediated inactivation of HER3 improves the antitumour activity and sensitivity of gefitinib in gastric cancer cells
por: Yuan, Heng-Heng, et al.
Publicado: (2017)

Inhibition of Mus81 by siRNA enhances sensitivity to 5-FU in breast carcinoma cell lines
por: Qian, Ying, et al.
Publicado: (2014)

Delivery of siRNA Using Functionalized Gold Nanorods Enhances Anti-Osteosarcoma Efficacy
por: Zhang, Man, et al.
Publicado: (2021)

siRNA-optimized Modifications for Enhanced In Vivo Activity
por: Kenski, Denise M, et al.
Publicado: (2012)

Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles
por: Kummitha, China M, et al.
Publicado: (2012)

Novel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor α by XCT790 and siRNA
por: Sun, PengMing, et al.
Publicado: (2018)

Redox-Sensitive Gelatin/Silica-Aptamer Nanogels for Targeted siRNA Delivery
por: Zhao, Xueqin, et al.
Publicado: (2019)

siRNA potency enhancement via chemical modifications of nucleotide bases at the 5′-end of the siRNA guide strand
por: Shinohara, Fumikazu, et al.
Publicado: (2021)

Inhibition of retinal neovascularization by siRNA targeting VEGF(165)
por: Xia, Xiao-bo, et al.
Publicado: (2008)

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer
por: Zhang, Qiumo, et al.
Publicado: (2020)

Modulation of thermal stability can enhance the potency of siRNA
por: Addepalli, Haripriya, et al.
Publicado: (2010)

Chemokine decoy receptors in inflammation
por: Graham, G
Publicado: (2005)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
por: Berezhnoy, Alexey, et al.
Publicado: (2012)

Where should siRNAs go: applicable organs for siRNA drugs
por: Ahn, Insook, et al.
Publicado: (2023)

Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy
por: Ben-David-Naim, Meital, et al.
Publicado: (2019)

Nrf2-siRNA Enhanced the Anti-Tumor Effects of As(2)O(3) in 5-Fluorouracil-Resistant Hepatocellular Carcinoma by Inhibiting HIF-1α/HSP70 Signaling
por: Duan, Xuhua, et al.
Publicado: (2022)

Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients
por: Yang, Meisongzhu, et al.
Publicado: (2010)

siRNA targeting YAP gene inhibits gastric carcinoma growth and tumor metastasis in SCID mice
por: ZHOU, ZHOU, et al.
Publicado: (2016)

Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route
por: Meryet-Figuière, Matthieu, et al.
Publicado: (2017)

Sustained delivery of siRNA/PEI complex from in situ forming hydrogels potently inhibits the proliferation of gastric cancer
por: Peng, Hao, et al.
Publicado: (2016)

Co-delivery of Doxorubicin and Bmi1 siRNA by Folate Receptor Targeted Liposomes Exhibits Enhanced Anti-Tumor Effects in vitro and in vivo
por: Yang, Tan, et al.
Publicado: (2014)

Ultrasound-sensitive siRNA-loaded nanobubbles fabrication and antagonism in drug resistance for NSCLC
por: Su, Chunhong, et al.
Publicado: (2021)

Therapeutic siRNA: state of the art
por: Hu, Bo, et al.
Publicado: (2020)

siRNA-directed DNA Methylation in Plants
por: Xie, Meng, et al.
Publicado: (2015)

Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity
por: Satpathy, Minati, et al.
Publicado: (2016)

A rapid and sensitive assay for quantification of siRNA efficiency and specificity
por: Smart, Nicola, et al.
Publicado: (2005)

Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles
por: Pan, Jingtong, et al.
Publicado: (2018)

Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking
por: Mysinger, Michael M., et al.
Publicado: (2012)

Identification and Characterization of Receptor-Specific Peptides for siRNA Delivery
por: Ren, Yin, et al.
Publicado: (2012)

Efficient in vitro delivery of Noggin siRNA enhances osteoblastogenesis
por: Ghadakzadeh, S., et al.
Publicado: (2017)

Enhanced Cancer Theranostics with Self-Assembled, Multilabeled siRNAs
por: Kozuch, Stephen D., et al.
Publicado: (2018)

siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy
por: Xia, Yu, et al.
Publicado: (2018)

siRNA Suppression of NEDD9 Inhibits Proliferation and Enhances Apoptosis in Renal Cell Carcinoma
por: Wang, Jue, et al.
Publicado: (2015)

Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006)

siRNA for Influenza Therapy
por: Barik, Sailen
Publicado: (2010)

Retrovirus-delivered siRNA
por: Devroe, Eric, et al.
Publicado: (2002)

Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_piqcasnsq924j9kd5di533q2m9